微血清环境刺激对结直肠癌干细胞的提取和生物功能的影响
Feiqing Wang1,2, Jianing Zhao1, Chike Zhang3
1Clinical Medical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, No. 71 Bao Shan North Road, Yunyan District, Guiyang, 550001, Guizhou Province, China.
Discover oncology
|August 28, 2023
概括
将血清添加到3D癌症干细胞 (CSC) 培养物中可以增强球体形成,活力和自我更新. 这种微血清环境改善了结直肠癌干细胞 (CCSC) 丰富,并提高了瘤启动能力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 3D癌症干细胞 (CSC) 培养在体外瘤模型中至关重要.
- 结肠直肠癌干细胞 (CCSCs) 对瘤生长和复发至关重要.
- 了解影响CCSC丰富的因素是有效癌症研究的关键.
研究的目的:
- 研究微血清环境对CCSC提取和生物功能的影响.
- 在3D培养中确定最佳血清度以丰富CCSCs.
- 评估血清补充如何影响CSC标记物表达和瘤发生潜力.
主要方法:
- 在一个星期内,CCSCs在无血清介质中培养,血清度有所变化.
- 分析了CSC标记物 (CD133,CD44) 和干性基因的表达.
- 使用免疫缺陷小鼠模型评估瘤原生能力.
主要成果:
- 血清补充剂显著增加了球体的形成,大小和活力.
- 血清球体表现出CD133和CD44标记物的更高表达.
- 血清诱导的CSC显示增强了扩散,迁移,入侵和瘤启动能力.
- 血清添加促进了上皮质-介质细胞过渡 (EMT).
结论:
- 微血清环境刺激是可靠CCSC丰富的有效策略.
- 血清补充可以增强CCSCs的生物功能和瘤生成潜力.
- 这种方法为癌症研究中CCSC丰富提供了更有效的方法.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


